(Q40580539)

21 September 2017

In vivo inhibition of tumor angiogenesis by a soluble VEGFR-2 fragment (English)

1 reference

21 September 2017

1 reference

Baijun Kou

1

1 reference

21 September 2017

Yulin Li

2

1 reference

21 September 2017

Lihong Zhang

3

1 reference

21 September 2017

Guibin Zhu

4

1 reference

21 September 2017

Xinrui Wang

5

1 reference

21 September 2017

Yilei Li

6

1 reference

21 September 2017

Jianxin Xia

7

1 reference

21 September 2017

Yingai Shi

8

1 reference

21 September 2017

1 April 2004

1 reference

Experimental and Molecular Pathology

21 September 2017

1 reference

21 September 2017

76

1 reference

21 September 2017

129-137

1 reference

21 September 2017

2

1 reference

Expression of vascular endothelial growth factor and its receptors flt and KDR in ovarian carcinoma.

21 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

The biology of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Anti-angiogenesis: new concept for therapy of solid tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Blood vessel formation: what is its molecular basis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Role of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Regulation of the expression of the VEGF/VPS and its receptors: role in tumor angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Antiangiogenic gene therapy in a rat glioma model using a dominant-negative vascular endothelial growth factor receptor 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

High affinity VEGF binding and developmental expression suggest Flk-1 as a major regulator of vasculogenesis and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Endothelial receptor tyrosine kinases involved in angiogenesis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Mechanisms of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Current approaches to targeting cancer using antiangiogenesis therapies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Inhibition of vascular endothelial growth factor (VEGF)-induced endothelial cell proliferation by a peptide corresponding to the exon 7-encoded domain of VEGF165

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXMP.2003.10.010

10.1016/J.YEXMP.2003.10.010

7 January 2021

Identifiers

DOI

1 reference

21 September 2017

1 reference